Explore

Trendline Trendline
Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector
Trendline Trendline
Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery
Trendline Trendline
Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment
Reuters Reuters
Factbox-Global pharma companies that have publicly announced Trump drug pricing agreements

Factbox-Global pharma companies that have publicly announced Trump drug pricing agreements

April 2 (Reuters) - U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-year exemptions from tariffs on drug imports.
Trendline Trendline
Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom
Trendline Trendline
Eli Lilly's Market Dominance in Metabolic Health and Innovation

Eli Lilly's Market Dominance in Metabolic Health and Innovation

Eli Lilly's Market Dominance in Metabolic Health and Innovation
Trendline Trendline
SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio
Trendline Trendline
Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market

Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market

Eli Lilly's New GLP-1 Drug Approval Set to Transform Weight Loss Market
Trendline Trendline
Immunovant's Thyroid Eye Disease Drug Fails in Pivotal Trials, Shifts Focus to New Treatment

Immunovant's Thyroid Eye Disease Drug Fails in Pivotal Trials, Shifts Focus to New Treatment

Immunovant's Thyroid Eye Disease Drug Fails in Pivotal Trials, Shifts Focus to New Treatment
Reuters Reuters
Drugmakers face 100% tariff unless they cut prices or produce drugs in US

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

By Ahmed Aboulenein WASHINGTON, April 2 (Reuters) - The Trump administration said on Thursday it will impose 100% tariffs on branded pharmaceuticals imported into the United States unless manufacturers agree to government drug pricing deals or commit to making their products domestically.
Trendline Trendline
Alexandria Real Estate Equities Recognized as One of America's Most Trustworthy Companies by Newsweek

Alexandria Real Estate Equities Recognized as One of America's Most Trustworthy Companies by Newsweek

Alexandria Real Estate Equities Recognized as One of America's Most Trustworthy Companies by Newsweek
Trendline Trendline
SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services

SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services

SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services